Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Deloitte
QuintilesIMS
Dow
Cipla
Johnson and Johnson
Moodys
AstraZeneca
US Department of Justice

Generated: April 22, 2018

DrugPatentWatch Database Preview

ACETOHEXAMIDE Drug Profile

« Back to Dashboard

Which patents cover Acetohexamide, and when can generic versions of Acetohexamide launch?

Acetohexamide is a drug marketed by Ani Pharms Inc, Usl Pharma, and Watson Labs Teva. and is included in six NDAs.

The generic ingredient in ACETOHEXAMIDE is acetohexamide. There are six drug master file entries for this compound. Additional details are available on the acetohexamide profile page.
Drug patent expirations by year for ACETOHEXAMIDE
Medical Subject Heading (MeSH) Categories for ACETOHEXAMIDE
Synonyms for ACETOHEXAMIDE
1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea
1-(4-acetylbenzenesulfonyl)-3-cyclohexylurea
1-(4-acetylphenyl)sulfonyl-3-cyclohexyl-urea
1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea
1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea
1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea
1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide
1-[(p-Acetylphenyl)sulfonyl]-3-cyclohexylurea
1-Acetyl-4-(([(cyclohexylamino)carbonyl]amino)sulfonyl)benzene #
1-cyclohexyl-3-(4-ethanoylphenyl)sulfonyl-urea
3-(4-acetylbenzenesulfonyl)-1-cyclohexylurea
3-cyclohexyl-1-(p-acetylphenylsulfonyl)urea
4-acetyl-N-((cyclohexylamino)carbonyl)benzenesulf onamide
4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide
4-acetyl-N-(cyclohexylcarbamoyl)benzene-1-sulfonamide
4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide
4-Acetyl-N-[(cyclohexylamino)- carbonyl]benzenesulfonamide
4-Acetyl-N-[(cyclohexylamino)-carbonyl]benzenesulfonamide
4-Acetyl-N-[(cyclohexylamino)carbonyl]benzenesulfonamide
8054-32-8
968-81-0
A-178
A845651
AC1L1COE
Acetohexamid
Acetohexamida
Acetohexamida [INN-Spanish]
Acetohexamide (JP15/USP/INN)
Acetohexamide (JP17/USP/INN)
Acetohexamide [USAN:INN:BAN:JAN]
Acetohexamide [USAN:USP:INN:BAN:JAN]
Acetohexamide [USAN)
Acetohexamide Lilly Brand
Acetohexamide Salvat Brand
Acetohexamide, analytical standard
Acetohexamide, United States Pharmacopeia (USP) Reference Standard
Acetohexamidum
Acetohexamidum [INN-Latin]
AKOS015916290
API0002381
Benzenesulfonamide, 4-acetyl-N-((cyclohexylamino)carbonyl)-
Benzenesulfonamide, 4-acetyl-N-[(cyclohexylamino)carbonyl]-
BPBio1_000231
BRD-K52960356-001-03-1
BRN 2225115
BSPBio_000209
C-19808
C06806
C15H20N2O4S
CAS-968-81-0
CC-23668
CCG-204183
CCRIS 4
CHEBI:28052
CHEMBL1589
CTK8F7520
D00219
D07WFK
DB00414
Dimelin
dimelin (antidiabetic)
Dimelor
DR001466
DSSTox_CID_7
DSSTox_GSID_20007
DSSTox_RID_75319
DTXSID7020007
Dymelor
Dymelor (TN)
EINECS 213-530-4
EU-0100088
FT-0661053
Gamadiabet
GTPL6793
HMS1568K11
HMS2093H21
HMS2095K11
HMS2236M07
HMS3260A18
HMS3372B02
HSDB 3280
HY-B0881
Hypoglicil
I14-51513
KS-00001F9N
Lilly Brand of Acetohexamide
Lopac-A-178
Lopac0_000088
LP00088
LS-2019
MCULE-3744173137
Metaglucina
MFCD00072156
Minoral
MLS002154186
MolPort-003-666-680
N-(p-Acetylbenzenesulfonyl)-N'-cyclohexylurea
N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea
NCGC00015014-01
NCGC00015014-02
NCGC00015014-03
NCGC00015014-04
NCGC00015014-05
NCGC00015014-06
NCGC00015014-07
NCGC00015014-08
NCGC00015014-11
NCGC00016555-01
NCGC00091230-01
NCGC00091230-02
NCGC00091230-03
NCGC00091230-04
NCGC00256467-01
NCGC00259571-01
NCGC00260773-01
NCI-C03247
NSC-759128
NSC759128
OR067643
OR381445
ord imel
Ordimel
Pharmakon1600-01505425
Prestwick_3
Prestwick0_000055
Prestwick1_000055
Prestwick2_000055
Prestwick3_000055
QGC8W08I6I
Salvat Brand of Acetohexamide
SBI-0050076.P002
SC-70790
SCHEMBL37620
SMR001233477
SPBio_002130
SR-01000075539
SR-01000075539-1
Tox21_110067
Tox21_110067_1
Tox21_202022
Tox21_302735
Tox21_500088
Tsiklamid
U 14812
U-14812
UNII-QGC8W08I6I
Urea, 1-((p-acetylphenyl)sulfonyl)-3-cyclohexyl-
Urea, 1-[(p-acetylphenyl)sulfonyl]-3-cyclohexyl-
VGZSUPCWNCWDAN-UHFFFAOYSA-N
VZ31185
Z1558572527
ZINC18067894

US Patents and Regulatory Information for ACETOHEXAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc ACETOHEXAMIDE acetohexamide TABLET;ORAL 070869-001 Feb 9, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Usl Pharma ACETOHEXAMIDE acetohexamide TABLET;ORAL 070754-001 Nov 3, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms Inc ACETOHEXAMIDE acetohexamide TABLET;ORAL 070870-001 Feb 9, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Usl Pharma ACETOHEXAMIDE acetohexamide TABLET;ORAL 070753-001 Nov 3, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Covington
Chubb
Harvard Business School
US Army
Accenture
Dow
QuintilesIMS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.